Black men are more likely to get follow up care and to mention other health concerns after visiting a black doctor, a new Stanford study has found.
Could social media — where misinformation is too often spread — be a place to help build trust in science and the research enterprise?
Targeted screening can cut hepatitis B related deaths in the U.S. by half - and save money.
A diabetes program, developed with a Stanford scientist, helps cut costs of diabetes-related health care expenses by $815 per year per person.
Researchers engaged citizen scientists to take photos and collect other data to investigate how neighborhoods can affect health.
Children aren’t getting access to many new medical devices, but the U.S. Food and Drug Administration is working to change that.
A Stanford pediatric trauma expert discusses children's separation from their parents at the border and shares how childhood trauma can harm the brain.
Pediatric resident Jennifer DeCoste-Lopez emphasizes the importance of nurturing caregivers and decries policies that separate children from parents.
Victor Fuchs, known for his lifelong contributions to health economics, recently celebrated the publication of his new book "Health Economics and Policy: Selected Writings" with a talk on campus.
Most participants in clinical trials believe the benefits of broadly sharing individual data outweigh the risks, a new Stanford study has found.
A working paper from Stanford scholars finds evidence that some consumers who buy their own insurance have taken advantage of the ACA provision preventing discrimination based on preexisting conditions to strategically pop in and out of coverage in ACA marketplaces.
A majority of primary care doctors report frustration with how electronic health records have affected their relationships with patients and with the amount of time required by the systems, according to a Stanford poll commissioned from The Harris Poll. However, many also say EHRs have led to improved patient care.
A team of researchers has updated and improved the equations that guide prescribing decisions for physicians in the U.S. regarding cardiovascular risk.
It’s one of the hardest questions in medicine: Should hospitals ever stop spending money to avert certain preventable deaths?
Stanford's David Ouyang sifted through more than a million texts to find out if clinicians inadvertently endorse brand-name medications over less expensive generic alternatives.
Howard Koh, MD, former assistant secretary of health in the Obama Administration, spoke recently in a Stanford Health Policy Forum discussion.